GSK Plc (NYSE:GSK) Given Average Recommendation of "Hold" by Brokerages
Shares of GSK plc (NYSE:GSK – Get Rating) have earned an average recommendation of "Hold" from the fifteen research firms that are covering the stock, Marketbeat.com reports. Three investment analys
The Use of Artificial Intelligence in Medical Devices and Drug Development
Preview -- Barron's
Monday 1/30 Franklin Resources, GE HealthCare Technologies, and NXP Semiconductors report quarterly results. Tuesday 1/31 Advanced Micro Devices, Amgen, Caterpillar, Chubb, Edwards Lifesciences, El
Vir Upgraded at Morgan Stanley Citing Multiple Catalysts in 2023
GSK (GSK) Scheduled to Post Quarterly Earnings on Wednesday
GSK (NYSE:GSK – Get Rating) is set to post its quarterly earnings results before the market opens on Wednesday, February 1st. Analysts expect GSK to post earnings of $0.59 per share for the quarter.
GSK's Belimumab Granted Orphan Designation as Treatment of Systemic Sclerosis
Pharma Stocks Weigh Down European Equities in Tuesday Trading
11:11 AM EST, 01/24/2023 (MT Newswires) -- European equities were moving lower in Tuesday trading, weighed down by pharmaceutical firms, as American depositary receipts of European stocks declined 0.5
GSK Earnings Conference Call Is Coming Up, Here's What You Need To Know
GSK (NYSE:GSK) will host a conference call at 06:00 AM ET on February 1, 2023, to discuss Q4 2022 earnings results.How to Attend GSK (GSK) Conference CallFollow this link to access the live webcast.To
'Pharma Bro' Martin Shkreli Faces FTC’s Contempt of Court Charges Over New Drug Firm
Injectable Drugs Global Market Report 2022: Featuring Amgen, Novo Nordisk, Pfizer, Novartis, Merck, GlaxoSmithKline & More - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Injectable Drugs Market, By Molecule Type, By Drug Class, By Application, and By Geography - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028" report has been
Loading...
No Stock Yet